Concepedia

Sanad M. El-Khatib

SM

Statistics

Publications

3

Citations

67

H-Index

3

Active since

2023

Affiliations

University of California, Irvine(Current)

Sanad M. El-Khatib is an author at University of California, Irvine specializing in anthracycline-based chemotherapy, cancer pharmacology, and supportive care in neuro-oncology.

ORCID

Publications per year

2023–2025

3

Publications

3

BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis

Manal T. Usmani, Robert P. Krattli, Sanad M. El-Khatib et al. · Neurotherapeutics · 2023 · 42 citations · Full text

, , +17

BDNF augmentation reverses cranial radiation therapy-induced cognitive decline and neurodegenerative consequences

Sanad M. El-Khatib, Arya R. Vagadia, Anh C. D. Le et al. · Acta Neuropathologica Communications · 2024 · 14 citations · Full text

, , +17

Immune checkpoint inhibition perturbs neuro-immune homeostasis and impairs cognitive function

Onwodi V. Ifejeokwu, An H., Sanad M. El-Khatib et al. · Journal of Experimental & Clinical Cancer Research · 2025 · 11 citations · Full text

, , +17

1–3 of 3